Feed aggregator

Tetra's Alzheimer's Drug Improves Language, Learning in Fragile X Syndrome

Biospace news - Fri, 04/30/2021 - 02:00
An investigational Alzheimer's disease drug from Tetra Therapeutics appeared to improve language ability and learning in adults with Fragile X Syndrome, according to a new study reported in Nature Medicine.

BioSpace Movers & Shakers, April 30

Biospace news - Fri, 04/30/2021 - 02:00
Biopharma and life sciences companies strengthen their leadership teams and boards with these Movers & Shakers.

Research Roundup: Underlying Conditions, COVID-19 Severity and More

Biospace news - Fri, 04/30/2021 - 02:00
Every week there are numerous scientific studies published. Here’s a look at some of the more interesting ones.

India's Double Mutant Strain Raises Concern, But Companies Confident on Vaccine Effectiveness

Biospace news - Fri, 04/30/2021 - 02:00
A study found in India that the existing COVID-19 vaccines should be effective against the Indian variant, not just the Pfizer-BioNTech vaccine.

AstraZeneca Q1: Strong Growth with Some Pipeline Clean-up

Biospace news - Fri, 04/30/2021 - 02:00
AstraZeneca reported its first-quarter financial reports. As is often the case, they updated their pipeline, and indicated they had dropped a few drugs, including a promising multiple myeloma drug.

Novartis signs initial agreement to reserve capacity and implement the technology transfer for the production of the active pharmaceutical ingredient for Roche's Actemra/RoActemra®

World Pharma News - Thu, 04/29/2021 - 12:00
Novartis has signed an initial agreement with Roche to reserve capacity and implement the technology transfer for the production of the active pharmaceutical ingredient (API) for Roche's Actemra/RoActemra® (tocilizumab), a treatment for rheumatoid arthritis which is also being tested in various clinical trials investigating the safety and efficacy in COVID-19 associated pneumonia.

Moderna announces additional investments to increase global supply for COVID-19 vaccine to up to 3 billion doses in 2022

World Pharma News - Thu, 04/29/2021 - 10:00
Moderna, Inc. (Nasdaq: MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced it is making new funding commitments to increase supply at its owned and partnered manufacturing facilities, which it expects will increase global 2022 capacity to up to 3 billion doses of its COVID-19 vaccine,

Four Biotechs Rake in Over $350 Million for Rare Diseases, Cancers and More

Biospace news - Thu, 04/29/2021 - 02:00
Ohio-based Forge Biologics secured $120 million in a Series B financing round to support the clinical development of its gene therapy program for rare diseases, including the typically fatal Krabbe disease.

Biopharma Companies Wrestle with Staffing Situations and Shortages from Pandemic

Biospace news - Thu, 04/29/2021 - 02:00
Work-at-home arrangements created to respond to the COVID-19 pandemic have forced numerous companies in most sectors to reevaluate their work deals. This has also resulted in rethinking site locations and real estate needs. Here’s a look.

COVID-19 Brief: Atea Initiates Phase III for Investigational Antiviral, BioNTech Tests Vaccine in...

Biospace news - Thu, 04/29/2021 - 02:00
The battle against COVID-19 rages on, and other therapeutics are making their way through the clinic, including monoclonal antibody treatments and antivirals. BioSpace takes a look at some of the ongoing efforts to stem the rate of infection from the virus.

Biden Proposes New $6.5 Billion Advanced Research Agency to End Cancer

Biospace news - Thu, 04/29/2021 - 02:00
Cancer doesn’t care if you’re Democratic, Republican, Libertarian or Green. It strikes without prejudice or consideration. As President Joe Biden said Wednesday night in his first major speech to Congress, “I know of nothing that is more bipartisan.”

Acceleron Finds Itself in FDA's Crosshairs After Failure to Post Clinical Data Summary

Biospace news - Thu, 04/29/2021 - 02:00
The FDA is threatening Acceleron with a $10,000 fine or criminal prosecution, charging the company with failure to post a summary of study data on its cancer combo dalantercept and axitinib in the ClinicalTrials.gov online database.

Good Isn't Good Enough: Moderna Continues Efforts to Improve COVID-19 Vaccine

Biospace news - Thu, 04/29/2021 - 02:00
Moderna, one of three companies to have a COVID-19 vaccine authorized in the U.S., isn’t resting on its accomplishments but is instead working to scale up production further and improve on its vaccine.

Global Roundup: UK Expands Life Sciences Ecosystem with Formation of We Are Pioneering Group

Biospace news - Thu, 04/29/2021 - 02:00
Biopharma and life sciences companies from across the globe provide updates on their businesses and pipelines.

Biotech Tilts at the Tipping Point of Gender Equality

Biospace news - Thu, 04/29/2021 - 02:00
A recent report by Deerfield Management Company revealed an unsettling but unsurprising truth: There is a significant gender gap on the boards of venture-backed healthcare companies.

FDA Blocks Biogen's sBLA for MS Drug

Biospace news - Thu, 04/29/2021 - 02:00
The U.S. FDA says it is unable to approve Biogen supplemental Biologic License Application (sBLA) for subcutaneously delivered TYSABRI® for the treatment of relapsing multiple sclerosis (MS), at least while the sBLA remains in its present form.

Set Post-Pandemic Career Goals with These Tips

Biospace news - Thu, 04/29/2021 - 02:00
If you’re setting new career goals, try including these tips to shape a path forward.

3 Ways to Pivot Your Current Job Instead of Looking for a New One

Biospace news - Thu, 04/29/2021 - 02:00
After you’ve been in a role for a decent amount of time it can feel like you have learned all that there is to learn. But that’s not to say that you’ve learned all you can from the company and the people that work there.

Brazilian coronavirus variant likely to be more transmissible and able to evade immunity

World Pharma News - Wed, 04/28/2021 - 12:00
Even though more and more vaccines against the coronavirus are being administered all over the world, many countries are still battling with outbreaks and face difficulties providing help to those in need.

One of those countries is Brazil. Here, they are facing a massive second wave outbreak, many daily deaths and instances of the health care systems collapsing.

Pfizer acquires Amplyx Pharmaceuticals

World Pharma News - Wed, 04/28/2021 - 10:00
Pfizer Inc. (NYSE: PFE) announced today that it has acquired Amplyx Pharmaceuticals, Inc., a privately-held company dedicated to the development of therapies for debilitating and life-threatening diseases that affect people with compromised immune systems. Amplyx's lead compound, Fosmanogepix (APX001), is a novel investigational asset under development for the treatment of invasive fungal infections.